General MedicationsTOPICALStandard
TACROLIMUS
TACROLIMUS
Standard Dose
0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TACROLIMUS is listed in Drugs@FDA under application 212387 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TACROLIMUS Form and strength OINTMENT;TOPICAL - 0.1% Sponsor ENCUBE Submission history Latest submission status date: 2023-10-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview TACROLIMUS is listed in Drugs@FDA under application 212387 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TACROLIMUS Form and strength OINTMENT;TOPICAL - 0.1% Sponsor ENCUBE Submission history Latest submission status date: 2023-10-10 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.